BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8413750)

  • 1. [Local injection treatment with botulinum toxin A in severe arm and leg spasticity].
    Konstanzer A; Ceballos-Baumann AO; Dressnandt J; Conrad B
    Nervenarzt; 1993 Aug; 64(8):517-23. PubMed ID: 8413750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of spasticity with botulinum toxin].
    Mémin B; Pollak P; Hommel M; Perret J
    Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of spasticity with botulinum toxin: a double-blind study.
    Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
    Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in treating spasticity.
    Das TK; Park DM
    Br J Clin Pract; 1989 Nov; 43(11):401-3. PubMed ID: 2611094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hip adductor spasticity with botulinum toxin type B].
    Oechsner M
    Nervenarzt; 2002 Dec; 73(12):1179-82. PubMed ID: 12486568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long-term treatment].
    Takenaga S; Kawahigashi Y; Sonoda Y; Horikiri T; Hirata K; Arimura K; Osame M
    Rinsho Shinkeigaku; 1995 Mar; 35(3):251-5. PubMed ID: 7614746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinum toxin in stroke patients with severe upper limb spasticity.
    Bhakta BB; Cozens JA; Bamford JM; Chamberlain MA
    J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):30-5. PubMed ID: 8676154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.